We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cispharma Warned About Failure To Develop Robust Quality System
Cispharma Warned About Failure To Develop Robust Quality System
July 26, 2013
The FDA is calling on OTC and generic drugmaker Cispharma to put together a strong quality system to address problems with batch mix-ups, coating defects and a poor investigation into an employee injury.